Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$240,627
in 2 filings, $39K under 10b5-1 plans

Net −$240,627. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Nofi Michael −$202K Chief Financial Officer sold 41% of stake
  2. Donovan Joanne M. −$39K CMO sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-05 Thompson Peter A. Director Grant or award · Stock Option (Right to Buy) +16,377 16,377
2025-06-16 Thompson Peter A. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2025-04-03 Thompson Peter A. Director Purchase +372,578 $20.13 $7.5M 14,809,075
2025-04-03 Thompson Peter A. Director Purchase +124,193 $20.13 $2.5M 443,792
2024-06-10 Thompson Peter A. Director Grant or award · Stock Options (Right to buy) +20,594 20,594
2024-01-23 Thompson Peter A. Director Purchase +454,545 $11.00 $5.0M 14,436,497
2023-06-12 Thompson Peter A. Director Grant or award · Stock Option (Right to Buy) +22,123 22,123
2022-09-16 Thompson Peter A. Director Purchase +484,496 $10.32 $5.0M 13,981,952
2022-06-24 Thompson Peter A. Director Grant or award · Stock Option (Right to Buy) +42,087 42,087
2022-05-18 Thompson Peter A. Director Purchase +138,000 $7.21 $995K 13,497,456
2021-03-30 Thompson Peter A. Director Conversion +12,730,036 13,046,956
2021-03-30 Thompson Peter A. Director Conversion +272,724 272,724
2021-03-30 Thompson Peter A. Director Purchase +46,875 $16.00 $750K 319,599
2021-03-30 Thompson Peter A. Director Purchase +312,500 $16.00 $5.0M 13,359,456
2021-03-30 Thompson Peter A. Director Conversion · Series A Preferred Stock −8,187,100 0
2021-03-30 Thompson Peter A. Director Conversion · Series B-1 Preferred Stock −1,572,960 0
2021-03-30 Thompson Peter A. Director Conversion · Series B-2 Preferred Stock −1,301,626 0
2021-03-30 Thompson Peter A. Director Conversion · Series C Preferred Stock −1,668,350 0
2021-03-30 Thompson Peter A. Director Conversion · Series C Preferred Stock −272,724 0

Page 1 of 1 · 19 trades